$330 Million is the total value of PIER 88 INVESTMENT PARTNERS LLC's 172 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SOLN | Southern Co/Thepreferred stock | $12,646,000 | +5.6% | 271,722 | 0.0% | 3.84% | +12.7% | |
| NEEPRO | NextEra Energy Incpreferred stock | $10,425,000 | +11.6% | 192,490 | 0.0% | 3.16% | +19.1% | |
| Southwest Airlines Coconvertible bonds | $8,843,000 | +8.7% | 6,775,000 | 0.0% | 2.68% | +16.0% | ||
| DHRPRA | Danaher Corppreferred stock | $6,823,000 | +18.4% | 4,623 | 0.0% | 2.07% | +26.3% | |
| Spirit Realty Capital Incconvertible bonds | $4,710,000 | +2.5% | 4,640,000 | 0.0% | 1.43% | +9.3% | ||
| Microchip Technology Incconvertible bonds | $4,600,000 | +4.4% | 2,986,000 | 0.0% | 1.40% | +11.5% | ||
| NEEPRP | NextEra Energy Incpreferred stock | $4,513,000 | +10.0% | 96,660 | 0.0% | 1.37% | +17.4% | |
| New Mountain Finance Corpconvertible bonds | $4,326,000 | +6.8% | 4,320,000 | 0.0% | 1.31% | +14.0% | ||
| TPG Specialty Lending Incconvertible bonds | $2,864,000 | +2.5% | 2,780,000 | 0.0% | 0.87% | +9.4% | ||
| Neurocrine Biosciences Inc 2.250000 05/15/2024convertible bonds | $454,000 | -17.3% | 330,000 | 0.0% | 0.14% | -11.5% | ||
| Prospect Capital Corpconvertible bonds | $207,000 | +10.7% | 205,000 | 0.0% | 0.06% | +18.9% | ||
| SLAB | Silicon Laboratories Inc | $196,000 | -2.5% | 2,001 | 0.0% | 0.06% | +3.5% | |
| NEWR | New Relic Inc | $184,000 | -18.2% | 3,265 | 0.0% | 0.06% | -12.5% | |
| MTOR | Meritor Inc | $180,000 | +5.9% | 8,600 | 0.0% | 0.06% | +14.6% | |
| TRHC | Tabula Rasa HealthCare Inc | $127,000 | -25.7% | 3,120 | 0.0% | 0.04% | -20.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MODEL N INC | 28 | Q3 2023 | 0.7% |
| HUBSPOT INC | 28 | Q3 2023 | 0.7% |
| MONOLITHIC PWR SYS INC | 26 | Q3 2023 | 0.8% |
| SPLUNK INC | 26 | Q3 2023 | 0.7% |
| SILICON LABORATORIES INC | 26 | Q3 2023 | 0.6% |
| WELLS FARGO CO NEW | 24 | Q3 2023 | 5.7% |
| ETSY INC | 24 | Q4 2022 | 0.7% |
| INSULET CORP | 22 | Q3 2023 | 0.7% |
| FARMLAND PARTNERS INC | 22 | Q3 2023 | 0.9% |
| Ultragenyx Pharmaceutical Inc | 22 | Q3 2023 | 0.4% |
View PIER 88 INVESTMENT PARTNERS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-10 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-09 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View PIER 88 INVESTMENT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.